Bi-allelic inactivation of VHL or VHL promotor hyper-methylation and subsequent VHL transcriptional repression underlie two thirds of sporadic ccRCC cases, and VHL mutations occur at the earliest point of tumor formation [6,7]. The gene discussed is VHL; the disease is neoplasm.